The store will not work correctly when cookies are disabled.
KV-37 , CAS No.K611364, Inhibitor of AKR1C3
Basic Description
Synonyms | AKR1C3 inhibitor KV-37 | 1954693-22-1 | CHEMBL4470997 | KV-37 | SCHEMBL20472116 | GTPL10262 | DTXSID701122793 | KV 37 | BDBM50509753 | BK168413 | (E)-3-[4-(3-methylbut-2-enyl)-3-(3-phenylpropanoylamino)phenyl]prop-2-enoic acid | (2E)-3-[4-(3-Methyl-2-buten-1-yl)-3-[(1-oxo-3-ph |
Specifications & Purity | Moligand™ |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of AKR1C3 |
---|
Associated Targets(Human)
Names and Identifiers
IUPAC Name | (E)-3-[4-(3-methylbut-2-enyl)-3-(3-phenylpropanoylamino)phenyl]prop-2-enoic acid |
INCHI | InChI=1S/C23H25NO3/c1-17(2)8-12-20-13-9-19(11-15-23(26)27)16-21(20)24-22(25)14-10-18-6-4-3-5-7-18/h3-9,11,13,15-16H,10,12,14H2,1-2H3,(H,24,25)(H,26,27)/b15-11+ |
InChi Key | SMYHHZFAWOLAAX-RVDMUPIBSA-N |
Canonical SMILES | O=C(Nc1cc(/C=C/C(=O)O)ccc1CC=C(C)C)CCc1ccccc1 |
Isomeric SMILES | CC(=CCC1=C(C=C(C=C1)/C=C/C(=O)O)NC(=O)CCC2=CC=CC=C2)C |
PubChem CID | 134817174 |
---|
References
1. Verma K, Gupta N, Zang T, Wangtrakluldee P, Srivastava SK, Penning TM, Trippier PC. (2018) AKR1C3 Inhibitor KV-37 Exhibits Antineoplastic Effects and Potentiates Enzalutamide in Combination Therapy in Prostate Adenocarcinoma Cells.. Mol Cancer Ther, 17 (9): (1833-1845). [PMID:29891491] |
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator